BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

S. Korean regulators start review on AstraZeneca vaccine for quick use in February

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : January 4, 2021, 16:03 | Updated : January 4, 2021, 16:03
  • 트위터
  • 페이스북
  • 웨이보
 

[Courtesy of SK Bioscience]


SEOUL -- State regulators have launched a process to approve the use of a COVID-19 vaccine produced by AstraZeneca PLC, a Swedish-British pharmaceutical company, and its South Korean consignment production partner. The examination will be completed within 40 days to start vaccination in February.

AstraZeneca has applied for permission to sell its vaccine which was produced by its South Korean partner, SK Bioscience, and abroad, the Ministry of Food and Drug Safety said, adding that South Korea would follow British rules to administer second doses four to 12 weeks after initial inoculation.

"We aim to complete our process within 40 days," Kim Sang-bong, who heads the ministry's biopharmaceutical bureau, told a press briefing on January 4. He said AstraZeneca's headquarters would analyze the quality equivalence of undiluted vaccine solution and finished products from SK Bioscience, which is also involved in South Korea's state project to develop COVID-19 vaccines.

U.S. biotech company Moderna has agreed to supply vaccine doses for 20 million people to South Korea starting in the second quarter of 2001. Moderna said it would begin delivering its vaccine to South Korea in May.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .GC Pharma shares up on expected consignment production deal with Moderna .
    GC Pharma shares up on expected consignment production deal …
  • .SK Bioscience ready to embark on second vaccines clinical trials.
    SK Bioscience ready to embark on second vaccine's clinical t…
  • .Celltrion leaves door open for consignment production of COVID-19 vaccines.
    Celltrion leaves door open for consignment production of COV…

Real Time Photo News

  • .Singer HyunA to end 14-month hiatus with mini-album Im Not Cool.

    Singer HyunA to end 14-month hiatus with mini-album 'I'm Not Cool'

  • .NCSofts global K-pop fan community platform to service original content including songs.

    NCSoft's global K-pop fan community platform to service original content including songs

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

Latest News

more+

  • Singer HyunA to end 14-month hiatus with mini-album 'I'm Not Cool'
  • S. Korea's medium-sized satellite ready for launch in March in Kazakhstan
  • Former coach gets jail term of over 10 years for sexually assaulting Olympic gold medalist
  • S. Korea demonstrates 20-minute ultra-fast EV chargers in southern resort island
  • Innovative electric vehicle charging station makes debut in Seoul as lifestyle complex
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view